Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Ofatumumab (OFA) Maintenance Prolongs PFS in Relapsed CLL: Prolong Study Interim Analysis Results

Marinus H.J. van Oers, Kazimierz Kuliczkowski, MD PhD Prof., Lukas Smolej, Mario Petrini, Fritz Offner, Sebastian Gorsicki, Mark-David Levin, Ira Gupta, Jennifer Phillips, Vanessa Williams, Steen Lisby, Christian Geisler

Blood (2014) 124 (21): 21.

https://doi.org/10.1182/blood.V124.21.21.21

Published: 2014

Journal Articles

The Hasford Score Correlates with the Long-Term Molecular Response to Imatinib Treatment for Chronic Myeloid Leukemia Patients and May be Useful for Differentiating Low and Intermediate Risk Patients: A Single Institution Experience

Jaroslaw Dybko, MD PhD, Ewa Medras, MD, Olga Haus, MD PhD, Bozena Jazwiec, MSC, Tomasz Wrobel, MDPhD, Kazimierz Kuliczkowski, MD PhD Prof.

Blood (2014) 124 (21): 3152.

https://doi.org/10.1182/blood.V124.21.3152.3152

Published: 2014

Journal Articles

Once-Weekly Prophylactic Treatment Versus on-Demand Treatment of Nonacog Alfa in Patients with Moderately Severe to Severe Hemophilia B

Kaan Kavakli, Lynne Smith, Kazimierz Kuliczkowski, MD PhD Prof., Joan Korth-Bradley, Chur Woo You, Joanne Fuiman, Silva Zupancic-Salek, Faraizah Abdul Karim, Pablo Rendo

Blood (2014) 124 (21): 1523.

https://doi.org/10.1182/blood.V124.21.1523.1523

Published: 2014

Journal Articles

High Expression of Mir-15a Predicts Shorter Survival and Worse Response to Chemotherapy in Patients with Acute Myeloid Leukemia (AML)

Aleksandra Butrym, MD PhD, Dagmara Baczynska, PhD, Andrzej Tukiendorf, Prof., Justyna Rybka, MD PhD, Tadeusz Dobosz, Prof., Wojciech Jurczak, Kazimierz Kuliczkowski, MD PhD Prof., Grzegorz Mazur, Prof.

Blood (2014) 124 (21): 5330.

https://doi.org/10.1182/blood.V124.21.5330.5330

Published: 2014

Journal Articles

Daunorubicine, Cytarabine and Cladribine (DAC) Vs Daunorubicine and Cytarabine (DA) Induction Treatment in Elderly Acute Myeloid Leukemia (AML) Patients – Results of the Prospective, Multicenter, Randomized Trial of the Polish Adult Leukemia Group (PALG)

Blood (2012) 120 (21): 3602.

https://doi.org/10.1182/blood.V120.21.3602.3602

Published: 2012

Journal Articles

Role of Second Stem Cell Transplantation in Relapsed Lymphoproliferative Diseases: Remission Status Is the Most Important Factor Predicting the Outcome

Lidia Gil, MD PhD, Jan Styczynski, MD, PhD, Agnieszka Piekarska, MD PhD, Beata Jakubas, MD PhD, Katarzyna Drabko, MD PhD, Tomasz Wrobel, prof., Anna Czyz, MD PhD, Anna Lojko-Dankowska, MD PhD, Dominik Dytfeld, MD PhD, Adam Nowicki, MD, Patrycja Mensah-Glanowska, MD PhD, Wanda Knopinska-Posluszny, MD, PhD, Maria Bieniaszewska, MD PhD, Mariusz Wysocki, MD, PhD, Andrzej Hellmann, MD, PhD, Aleksander Skotnicki, Jerzy Kowalczyk, Kazimierz Kuliczkowski, MD PhD, prof., Mieczyslaw Komarnicki, MD PhD

Blood (2011) 118 (21): 3109.

https://doi.org/10.1182/blood.V118.21.3109.3109

Published: 2011

Journal Articles

High Expression of Haematopoietic Cell Specyfic Lyn Substrate-1 (HS1) Predicts Survival of B-Cell Chronic Lymphocytic Leukemia Patients

Aleksandra Butrym, MD, PhD, Miroslaw Majewski, MD, Justyna Dzietczenia, MD, PhD, Tomasz Wrobel, prof., Kazimierz Kuliczkowski, MD PhD, prof., Grzegorz Mazur, prof.

Blood (2011) 118 (21): 2853.

https://doi.org/10.1182/blood.V118.21.2853.2853

Published: 2011

Journal Articles

CD8+CD28− in Peripheral Blood of Patients with Cutaneus T-Cell Lymphoma (CTLC) in Different Clinical Stages.

Donata M. Urbaniak-Kujda, MD, PhD, Katarzyna L. Kapelko-Slowik, MD, PhD, Bozena Jazwiec, MS, Joanna Maj, MD, PhD, Jaroslaw Dybko, MD, Miroslaw Slowik, MD, PhD, Dariusz Wolowiec, MD, PhD, Irena Frydecka, MD, PhD, Kazimierz Kuliczkowski, MD, PhD

Blood (2007) 110 (11): 4395.

https://doi.org/10.1182/blood.V110.11.4395.4395

Published: 2007

Journal Articles

Expression of the Human PIM-2 (hPIM-2) Gene in Patients with Acute Myeloblastic Leukaemia (AML) and Acute Lymphoblastic Leukaemia (ALL).

Katarzyna L. Kapelko-Slowik, MD, PhD, Donata M. Urbaniak-Kujda, MD, PhD, Bozena Jazwiec, MS, Jaroslaw Dybko, MD, Dariusz Wolowiec, MD, PhD, Miroslaw Slowik, MD, PhD, Irena Frydecka, MD, PhD, Kazimierz Kuliczkowski, MD, PhD

Blood (2007) 110 (11): 4288.

https://doi.org/10.1182/blood.V110.11.4288.4288

Published: 2007

Journal Articles

Gene Polymorphisms of Costimulatory Molecules: CTLA-4/CD28/ICOS Are Associated with B-Cell Chronic Lymphocytic Leukemia (B-CLL).

Irena Frydecka, MD, PhD, Katarzyna Suwalska, PhD, Edyta Pawlak, MSci, Lidia Karabon, PhD, Anna Tomkiewicz, MSci, Tadeusz Dobosz, PhD, Donata Urbaniak-Kujda, MD, Kazimierz Kuliczkowski, MD, PhD, Dariusz Wolowiec, MD, PhD

Blood (2007) 110 (11): 2074.

https://doi.org/10.1182/blood.V110.11.2074.2074

Published: 2007

Journal Articles

Association of T Cell Costimulatory and Downregulatory Gene Polymorphisms and Susceptibility to Multiple Myeloma.

Irena Frydecka, MD, PhD, Edyta Pawlak, M.Sc, Lidia Karabon, PhD, Ewa Sowinska, MD, Anna Jonkisz, M.Sc, Arleta Lebioda, M.Sc, Tadeusz Dobosz, PhD, Katarzyna Suwalska, PhD, Anna Tutak, M.Sc, Kazimierz Kuliczkowski, MD, PhD

Blood (2006) 108 (11): 5002.

https://doi.org/10.1182/blood.V108.11.5002.5002

Published: 2006

Journal Articles

High Incidence of Ancestral HLA Haplotype 8.1 and Incomplete DH-JH Immunoglobulin Rearrangement in Persistent Polyclonal B-Cell Lymphocytosis.

Dariusz Wolowiec, MD, PhD, Miroslaw Majewski, MD, Jacek Nowak, MD, PhD, Beata Stella-Holowiecka, MD, PhD, Angelika Krawcewicz, MD, Renata Mika-Witkowska, Hanna Makuch-Lasica, Iwona Solarska, Olga Haus, MD, PhD, Ewa Duszenko, Kazimierz Kuliczkowski, MD, PhD, Krzysztof Warzocha, MD, PhD

Blood (2005) 106 (11): 3923.

https://doi.org/10.1182/blood.V106.11.3923.3923

Published: 2005

NARROW

Ofatumumab (OFA) Maintenance Prolongs PFS in Relapsed CLL: Prolong Study Interim Analysis Results

The Hasford Score Correlates with the Long-Term Molecular Response to Imatinib Treatment for Chronic Myeloid Leukemia Patients and May be Useful for Differentiating Low and Intermediate Risk Patients: A Single Institution Experience

Once-Weekly Prophylactic Treatment Versus on-Demand Treatment of Nonacog Alfa in Patients with Moderately Severe to Severe Hemophilia B

High Expression of Mir-15a Predicts Shorter Survival and Worse Response to Chemotherapy in Patients with Acute Myeloid Leukemia (AML)

Daunorubicine, Cytarabine and Cladribine (DAC) Vs Daunorubicine and Cytarabine (DA) Induction Treatment in Elderly Acute Myeloid Leukemia (AML) Patients – Results of the Prospective, Multicenter, Randomized Trial of the Polish Adult Leukemia Group (PALG)

Role of Second Stem Cell Transplantation in Relapsed Lymphoproliferative Diseases: Remission Status Is the Most Important Factor Predicting the Outcome

High Expression of Haematopoietic Cell Specyfic Lyn Substrate-1 (HS1) Predicts Survival of B-Cell Chronic Lymphocytic Leukemia Patients

CD8+CD28− in Peripheral Blood of Patients with Cutaneus T-Cell Lymphoma (CTLC) in Different Clinical Stages.

Expression of the Human PIM-2 (hPIM-2) Gene in Patients with Acute Myeloblastic Leukaemia (AML) and Acute Lymphoblastic Leukaemia (ALL).

Gene Polymorphisms of Costimulatory Molecules: CTLA-4/CD28/ICOS Are Associated with B-Cell Chronic Lymphocytic Leukemia (B-CLL).

Association of T Cell Costimulatory and Downregulatory Gene Polymorphisms and Susceptibility to Multiple Myeloma.

High Incidence of Ancestral HLA Haplotype 8.1 and Incomplete DH-JH Immunoglobulin Rearrangement in Persistent Polyclonal B-Cell Lymphocytosis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only